Discusses research being done on the efficacy of therapeutic guidelines in reducing proven mortality resulting from Candida infection in high-risk neonates. Analysis of mortality by candidemia; Administration of antifungal therapy to newborns involved in the study; Characteristics of newborns with proven Candida sepsis.